/Investor DB

TRANSFORMATION CAPITAL — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Aktanaaktana.cominSeries C · Oct 2020 · $21M

Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times.

AI & Machine LearningEnterprise SoftwareSales TechSan Francisco, US

David J. Ehrlich(Executive Officer, Director)Derek Choy(Founder)inJin Huang(Executive Officer)Rob Willson(Executive Officer)Marc-david Cohen(Executive Officer)

BoardAnthony Glenning(Director)

Board seatJared Kesselheim· per SEC Form D

Co-investors1315 CapitalHLM Investment PartnersNorwest Venture PartnersStarfish VenturesUpfront VenturesB4 Capital

Datavantdatavant.cominSeries B · Oct 2020 · $40M

Datavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology.

AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech

Kyle Armbrester(Chief Executive Officer)in

Co-investorsFlex Capital PartnersGrand VenturesHealth Catalyst CapitalMerck Global Health Innovation FundMSD Global Health Innovation FundOctave+4 more

Oliveoliveai.comin𝕏Dec 2020 · $230Macquired by Waystar Holding

Olive was a Columbus, Ohio-based healthcare automation company that used AI and robotic process automation to handle administrative tasks like prior authorizations and revenue cycle workflows for hospitals.

AI & Machine LearningHealthtechSaaS

Co-investorsChicago VenturesDrive CapitalLRVHealthOak HC/FTAscension VenturesGeneral Catalyst

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

HQC Holdings

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.